Pharmacological Interventions for Clozapine-induced Hypersalivation
Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4
Abstract
Clozapine is widely used for people with schizophrenia. Agranulocytosis, weight gain, and cardiac problems are serious problems associated with clozapine use. Hypersalivation, sometimes of a gross and socially unacceptable quantity, is also common (30%–80%).
Authors and Affiliations
Rebecca J. Syed Sheriff, Katie Au, Caroline Cahill, Lorna Duggan, Yanling He, Victor Udu, Jun Xia
Keywords
Related Articles
- EP ID EP683281
- DOI 10.1093/schbul/sbn043
- Views 98
- Downloads 0
Implications of Clinical Trial Design on Sample Size Requirements
The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison group...
Implementation Considerations for Multisite Clinical Trials with Cognitive Neuroscience Tasks
Multisite clinical trials aimed at cognitive enhancement across various neuropsychiatric conditions have employed standard neuropsychological tests as outcome measures. While these tests have enjoyed wide clinical use an...
Imitation, Simulation, and Schizophrenia
The social significance of imitation is that it provides internal tools for understanding the actions of others by simulating or forming internal representations of these actions. Imitation plays a central role in human...
Making Progress in Schizophrenia Research
Measurement Issues in the Use of Cognitive Neuroscience Tasks in Drug Development for Impaired Cognition in Schizophrenia: A Report of the Second Consensus Building Conference of the CNTRICS Initiative
This overview describes the goals and objectives of the second conference conducted as part of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative. This second confere...